🔗 Permalink

Inventor profile of:

Pascale Andre

City:

Marseille

Country:

France

Published Applications:

Last publication date:

2024-11-07

Top Assignees for applications by Pascale Andre

The entities that hold a legal rights for patent applications filed by inventor Andre Pascale:

INNATE PHARMA 10 Marseilles, France
Novo Nordisk A/S 5 Bagsvaerd, Denmark
Innate Pharma SA 5 Marseille, France
UNIVERSITY OF GENOA 4 GENOA, Italy
Innate Pharma 3 Marseille, France
Innate Pharma, S.A. 3 Marseilles, France
Innate Pharma S.A.S. 3 Marseilles, France
BRISTOL-MYERS SQUIBB COMPANY 3 Princeton, NJ United States
UNIVERSITA DI GENOVA 2 Genova, Italy
University of Genova 2 Genoa, Italy
Novo Nordisk A/S—Novo Alle 1 Bagsvaerd, Denmark
INNATE PHARMA S.A.S 1 Marseille, France
INNATE PHARMA SA 1 Mareille, France
BRISTOL-MYERS SQUIBB COMPANY 1 NEW YORK, NY United States
BRISTOL-MYERS SQUIBB COMPANY 1 Princeston, NJ United States
Novo-Nordisk A/S - Novo Alle 1 Bagevaerd, Denmark
Novo-Nordisk A/S—Novo Alle 1 Bagevaerd, Denmark

Recent patent applications by Andre Pascale

Pascale Andre from Marseille, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-07

US20240368281A1

Chemistry; metallurgy

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

#2 | 2023-09-28

US20230303691A1

Chemistry; metallurgy

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

#3 | 2023-07-27

US20230235060A1

Chemistry; metallurgy

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

#4 | 2021-08-05

US20210238285A1

Chemistry; metallurgy

Treatment regimens using anti-NKG2A antibodies

#5 | 2021-04-29

US20210122821A1

Chemistry; metallurgy

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

#6 | 2020-10-22

US20200332008A1

Chemistry; metallurgy

Neutralization of inhibitory pathways in lymphocytes

#7 | 2020-09-24

US20200299383A1

Chemistry; metallurgy

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

#8 | 2019-10-24

US20190322744A1

Chemistry; metallurgy

Treatment of cancers using anti-NKG2A agents

#9 | 2019-05-09

US20190135938A1

Chemistry; metallurgy

MONOCLONAL ANTIBODIES AGAINST NKG2A

#10 | 2019-01-31

US20190031755A1

Chemistry; metallurgy

Neutralization of inhibitory pathways in lymphocytes

#11 | 2018-05-03

US20180117147A1

Human necessities

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

#12 | 2017-11-02

US20170313773A1

Chemistry; metallurgy

Treatment of cancers using anti-NKG2A agents

#13 | 2017-10-19

US20170298131A1

Chemistry; metallurgy

Treatment regimens using anti-NKG2A antibodies

#14 | 2017-10-12

US20170291947A1

Chemistry; metallurgy

Neutralization of inhibitory pathways in lymphocytes

#15 | 2016-09-08

US20160257750A1

Chemistry; metallurgy

Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma

#16 | 2015-12-31

US20150376275A1

Chemistry; metallurgy

ANTI-KIR ANTIBODIES FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISORDERS

#17 | 2015-12-03

US20150344576A1

Chemistry; metallurgy

HUMAN ANTI-KIR ANTIBODIES

#18 | 2015-10-08

US20150283234A1

Human necessities

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

#19 | 2015-07-09

US20150191547A1

Chemistry; metallurgy

HUMAN ANTI-KIR ANTIBODIES

#20 | 2015-05-14

US20150132316A1

Chemistry; metallurgy

MONOCLONAL ANTIBODIES AGAINST NKG2A

#21 | 2015-05-07

US20150125464A1

Chemistry; metallurgy

Monoclonal antibodies against NKG2A

#22 | 2014-07-10

US20140193430A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR REGULATING NK CELL ACTIVITY

#23 | 2013-10-31

US20130287770A1

Chemistry; metallurgy

Human anti-KIR antibodies

#24 | 2013-09-26

US20130251711A1

Human necessities

Methods for treatment of recurrent hematological malignancies

#25 | 2012-12-27

US20120328615A1

Chemistry; metallurgy

Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders

#26 | 2012-08-16

US20120208237A1

Chemistry; metallurgy

Nucleic acids encoding human anti-kir antibodies

#27 | 2011-09-22

US20110229486A1

Human necessities

Monoclonal Antibodies Against NKG2A

#28 | 2010-11-18

US20100291110A1

Chemistry; metallurgy

Compositions and methods for regulating NK cell activity

#29 | 2009-08-20

US20090208416A1

Human necessities

Monoclonal antibodies against NKG2A

#30 | 2009-07-30

US20090191213A9

Chemistry; metallurgy

Compositions and methods for regulating NK cell activity

#31 | 2009-03-26

US20090081240A1

Chemistry; metallurgy

Human anti-KIR antibodies

#32 | 2006-12-14

US20060280740A1

Chemistry; metallurgy

Compositions and methods for regulating NK cell activity

InventorID:

455125 ⎘